Profile
| Metric | Value |
|---|---|
| Full Name | GSK plc |
| Ticker | NYSE: GSK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | gsk.com |
| Employees | 68,629 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $48.22 | |
| Price, 1D Change | -1.83% | |
| Market Cap | $97B | |
| TTM Dividend Yield | 3.51% | |
| PE Ratio | 13.75 | |
| Beta | 0.23 | |
| Revenue | $40B | |
| Revenue, 1Y Change | +6.35% | |
| EPS | $1.59 | |
| EPS, 1Y Change | -46.69% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.43 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 613:500 | |
| Next Split | N/A | N/A |
| Last Ticker Change | GSK.V | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $1.59 | |
| EPS Estimate | $4.50 | |
| EPS Est. Change | +183.38% | |
| Revenue | $40.09B | |
| Revenue Estimate | $32.50B | |
| Revenue Est. Change | -18.94% | |
| Current Price | $48.22 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.97 | $2.98 | -24.93% | |
| $3.92 | $1.59 | -59.44% | |
| $4.50 | N/A | +183.38% | |
| $4.82 | N/A | +203.26% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $37.73B | $37.70B | -0.08% | |
| $31.16B | $40.09B | +28.66% | |
| $32.50B | N/A | -18.94% | |
| $34.04B | N/A | -15.10% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +44.20% | |
| Price, 3Y | +36.29% | |
| Market Cap, 1Y | +42.01% | |
| Market Cap, 3Y | +33.79% | |
| Revenue, 1Y | +6.35% | |
| Revenue, 3Y | +18.04% | |
| EPS, 1Y | -46.69% | |
| EPS, 3Y | -57.30% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $48.22 | |
| SMA 200 | $41.83 | |
| SMA 200 vs Price | -13.26% | |
| SMA 50 | $48.46 | |
| SMA 50 vs Price | +0.51% | |
| Beta | 0.23 | |
| ATR | $0.90 | |
| 14-Day RSI | 43.36 | |
| 10-Day Volatility | 28.82% | |
| 1-Year Volatility | 28.32% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.43 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 3.23% | |
| Total Dividend | $1.56 | |
| Dividends Paid | $3.12B | |
| Payout Ratio | 82.82% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $40.09B | |
| EPS | $1.59 | |
| Gross Profit | $27.98B | |
| Gross Margin | 69.80% | |
| Operating Profit | $5.14B | |
| Operating Margin | 12.82% | |
| Net Income | $3.77B | |
| Net Margin | 9.41% | |
| EBITDA | $9.11B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.24 | |
| Current Ratio | 0.78 | |
| Quick Ratio | 0.52 | |
| Interest Coverage | - | |
| F-Score | 7 | |
| Altman Z-Score | 1.86 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 13.75 | |
| PS Ratio | 2.30 | |
| PB Ratio | 4.46 | |
| EV/EBITDA | 8.00 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $17.15B | |
| Cash & Equivalents | $4.87B | |
| Total Assets | $74.47B | |
| Current Assets | $21.29B | |
| Total Liabilities | $58.08B | |
| Current Liabilities | $27.23B | |
| Total Debt | $21.27B | |
| Short Term Debt | $2.94B | |
| Accounts Payable | $4.34B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $34.96B | |
| Operating Expenses | $23.40B | |
| Cost Of Goods Sold | $12.11B | |
| SG&A | $253.01M | |
| D&A | $3.26B | |
| Interest Expense | $0.00 | |
| Income Tax | $672.13M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $7.78B | |
| CFI | -$1.77B | |
| CFF | -$5.24B | |
| Capex | $3.81B | |
| Free Cash Flow | $3.97B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| Jefferies | → | |
| Guggenheim | → | |
| UBS | → | |
| Jefferies | → | |
| Goldman Sachs | ||
| Guggenheim | → | |
| Morgan Stanley | ||
| Jefferies | → | |
| DZ Bank | → |
Analyst sentiment
Institutional ownership
Screeners with GSK
FAQ
What is the ticker symbol for GSK plc?
The ticker symbol for GSK plc is NYSE:GSK
Does GSK plc pay dividends?
Yes, GSK plc pays dividends. The last payment was $0.43, with an ex-dividend date on November 14, 2025
What sector is GSK plc in?
GSK plc is in the Healthcare sector
What industry is GSK plc in?
GSK plc is in the General Drug Manufacturers industry
What country is GSK plc based in?
GSK plc is headquartered in United Kingdom
When did GSK plc go public?
GSK plc initial public offering (IPO) was on March 28, 1980
Is GSK plc in the S&P 500?
No, GSK plc is not included in the S&P 500 index
Is GSK plc in the NASDAQ 100?
No, GSK plc is not included in the NASDAQ 100 index
Is GSK plc in the Dow Jones?
No, GSK plc is not included in the Dow Jones index
When was GSK plc last earnings report?
GSK plc's most recent earnings report was on October 29, 2025
When does GSK plc report earnings?
The next expected earnings date for GSK plc is February 4, 2026
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1131399/000113139925000007/0001131399-25-000007-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk